Echo IQ (ASX:EIQ) secured a definitive exclusive data licensing agreement with Advara HeartCare, according to a Thursday filing with the Australian bourse.
The agreement, which is for an initial three-year term with an option to extend for another three years, provides the company access to between 500,000 and 1 million de-identified echocardiography studies and associated relevant clinical datasets, the filing said.
Financial terms were not disclosed.